EP2474545 - Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 15.09.2017 Database last updated on 31.08.2024 | Most recent event Tooltip | 15.09.2017 | No opposition filed within time limit | published on 18.10.2017 [2017/42] | Applicant(s) | For all designated states Incyte Holdings Corporation 1801 Augustine Cut-Off Wilmington, DE 19803 / US | [2015/50] |
Former [2015/11] | For all designated states Incyte Corporation 1801 Augustine Cut-Off Wilmington, DE 19803 / US | ||
Former [2012/28] | For all designated states Incyte Corporation Experimental Station, Route 141 & Henry Clay Road, Building E336/225 Wilmington, DE 19880 / US | Inventor(s) | 01 /
Rodgers, James D. 2 Hillside Lane Landenberg, PA 19350 / US | 02 /
Shepard, Stacey 3407 Avalon Ct. Voorhees, NJ 08043 / US | 03 /
Maduskuie, Thomas P. 613 Foulkstone Road Wilmington, DE 19803 / US | 04 /
Wang, Haisheng 207 Hockessin Circle Hockessin, DE 19707 / US | 05 /
Falahatpisheh, Nikoo 1822 Foulk Road Wilmington, DE 19810 / US | 06 /
Rafalski, Maria 908 Fairthorne Avenue Greenville, DE 19807 / US | 07 /
Arvanitis, Argyrios G. 101 Willow Glen Drive Kennett Square, PA 19348 / US | 08 /
Storace, Louis 1409 Bohemia Mill Road Middletown, DE 19709 / US | 09 /
Jalluri, Ravi Kumar 234 Honey Locust Drive Avondale, PA 19311 / US | 10 /
Fridman, Jordan S. 50 Willow Creek Lane Newark, DE 19711 / US | 11 /
Vaddi, Krishna 108 Forest Drive Kennett Square, PA 19348 / US | [2012/28] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2016/45] |
Former [2012/28] | Howard, Paul Nicholas Carpmaels & Ransford One Southampton Row London WC1B 5HA / GB | Application number, filing date | 11152714.9 | 12.12.2006 | [2012/28] | Priority number, date | US20050749905P | 13.12.2005 Original published format: US 749905 P | US20060810231P | 02.06.2006 Original published format: US 810231 P | US20060850625P | 10.10.2006 Original published format: US 850625 P | US20060856872P | 03.11.2006 Original published format: US 856872 P | US20060859404P | 16.11.2006 Original published format: US 859404 P | [2012/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2474545 | Date: | 11.07.2012 | Language: | EN | [2012/28] | Type: | B1 Patent specification | No.: | EP2474545 | Date: | 09.11.2016 | Language: | EN | [2016/45] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 08.06.2012 | Classification | IPC: | C07D471/04, C07D487/04, A61K31/395, A61P17/00, A61P35/00, A61P37/00 | [2012/28] | CPC: |
A61K31/519 (EP,KR,US);
C07D471/04 (EA,US);
A61K31/395 (EA);
A61K31/437 (KR);
A61K31/573 (EP,KR,US);
A61K45/06 (EP,KR,US);
A61K9/0014 (KR,US);
A61K9/0053 (KR,US);
A61K9/20 (KR,US);
A61P17/00 (EA);
A61P17/04 (US);
A61P29/00 (US);
A61P31/12 (EP);
A61P35/00 (EA);
A61P35/04 (US);
A61P37/00 (EA,KR,US);
C07B59/002 (KR,US);
C07D417/04 (KR,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2016/45] |
Former [2012/28] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR | Extension states | AL | 10.01.2013 | BA | 10.01.2013 | HR | 10.01.2013 | MK | 10.01.2013 | RS | 10.01.2013 | Title | German: | Heteroarylsubstituierte Pyrrolo[2,3-b]pyridine sowie Pyrrolo[2,3-b]pyrimidine als Januskinaseinhibitoren | [2012/28] | English: | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors | [2012/28] | French: | Pyrrolo[2,3-b]pyridines et pyrrolo[2,3-b]pyrimidines à substitution hétéroaryle en tant qu'inhibiteurs de la janus kinase | [2012/28] | Examination procedure | 10.01.2013 | Amendment by applicant (claims and/or description) | 10.01.2013 | Examination requested [2013/16] | 07.03.2014 | Despatch of a communication from the examining division (Time limit: M06) | 15.10.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 23.12.2014 | Reply to a communication from the examining division | 13.02.2015 | Despatch of a communication from the examining division (Time limit: M06) | 19.08.2015 | Reply to a communication from the examining division | 29.09.2015 | Despatch of a communication from the examining division (Time limit: M06) | 08.04.2016 | Reply to a communication from the examining division | 18.05.2016 | Communication of intention to grant the patent | 28.09.2016 | Fee for grant paid | 28.09.2016 | Fee for publishing/printing paid | 28.09.2016 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP06839328.9 / EP1966202 | Divisional application(s) | EP16197502.4 / EP3184526 | EP18191992.9 / EP3466953 | EP20206996.9 / EP3838903 | Opposition(s) | 10.08.2017 | No opposition filed within time limit [2017/42] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 23.12.2014 | Request for further processing filed | 23.12.2014 | Full payment received (date of receipt of payment) Request granted | 13.01.2015 | Decision despatched | 07.03.2012 | Request for further processing filed | 07.03.2012 | Full payment received (date of receipt of payment) Request granted | 16.04.2012 | Decision despatched | The application is deemed to be withdrawn due to non-payment of the search fee | 05.07.2011 | Request for further processing filed | 05.07.2011 | Full payment received (date of receipt of payment) Request granted | 05.10.2011 | Decision despatched | The application is deemed to be withdrawn due to non-payment of the filing fee | 05.07.2011 | Request for further processing filed | 05.07.2011 | Full payment received (date of receipt of payment) Request granted | 05.10.2011 | Decision despatched | Fees paid | Renewal fee | 27.05.2011 | Renewal fee patent year 03 | 27.05.2011 | Renewal fee patent year 04 | 27.05.2011 | Renewal fee patent year 05 | 27.12.2011 | Renewal fee patent year 06 | 26.12.2012 | Renewal fee patent year 07 | 27.12.2013 | Renewal fee patent year 08 | 29.12.2014 | Renewal fee patent year 09 | 28.12.2015 | Renewal fee patent year 10 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XD]WO9965909 (PFIZER PROD INC [US], et al); | [AD]WO0142246 (PFIZER PROD INC [US], et al); | [A]WO0200661 (PFIZER PROD INC [US], et al); | [YD]US2004009983 (COX PAUL J [US], et al); | [AD]WO2004099204 (ASTRAZENECA AB [SE], et al); | [AD]WO2004099205 (ASTRAZENECA AB [SE], et al); | [X]WO2005013986 (PHARMACIA ITALIA SPA [IT], et al); | [A]US2005153989 (GROTZFELD ROBERT M [US], et al); | [YP]WO2006096270 (VERTEX PHARMA [US], et al); | [XP]WO2006127587 (VERTEX PHARMA [US], et al) | by applicant | US5521184 | WO9962908 | WO9965909 | WO0009495 | WO0053595 | WO0114402 | WO0142246 | WO0164655 | WO03024967 | WO03037347 | WO03099771 | WO2004005281 | WO2004046120 | WO2004056786 | WO2004072063 | WO2004080980 | US2004198737 | WO2004099204 | WO2004099205 | WO2005028444 | WO2006056399 | US20040578491 | EP20050009967 | EP20050010408 |